1. Home
  2. CCM vs CLGN Comparison

CCM vs CLGN Comparison

Compare CCM & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concord Medical Services Holdings Limited

CCM

Concord Medical Services Holdings Limited

N/A

Current Price

$4.25

Market Cap

23.8M

Sector

Health Care

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

N/A

Current Price

$1.41

Market Cap

23.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCM
CLGN
Founded
1997
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Medical/Nursing Services
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
23.1M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CCM
CLGN
Price
$4.25
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.50
AVG Volume (30 Days)
3.2K
24.0K
Earning Date
09-26-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$51,056,841.00
$2,475,000.00
Revenue This Year
N/A
$1,617.28
Revenue Next Year
N/A
$83.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
280.77
52 Week Low
$3.54
$1.31
52 Week High
$10.77
$4.98

Technical Indicators

Market Signals
Indicator
CCM
CLGN
Relative Strength Index (RSI) 47.23 24.98
Support Level $4.12 $1.77
Resistance Level $4.99 $1.93
Average True Range (ATR) 0.26 0.14
MACD 0.10 -0.06
Stochastic Oscillator 48.96 0.00

Price Performance

Historical Comparison
CCM
CLGN

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: